'Cancer: something evil or malignant that spreads destructively'
This definition took from the Merriam-Webster dictionary depicts perfectly how cancer affects the human population around the world. In order to fight properly this 'evil', we need to get a better understanding of how cancer occurs and how it can spread so efficiently. To achieve this task, it is essential to gain insights on how cells can be regulated as defective proliferation and differentiation are directly associated with tumour formation. Among the animal models used by scientists to elucidate the 'nuts and bolts' of these cellular processes, a little crawling creature containing less than a thousand cells known as Caenorhabditis elegans has been so far extremely successful in providing us important clues on these issues.
Initial studies led by John Sulston and H Robert Horvitz in Sidney Brenner's laboratory at Cambridge University, have allowed to obtain a precise and complete lineage of every single cell of an entire animal. This phenomenal work led to the discovery of a critical biological phenomenon essential to contain cell proliferation: apoptosis. Their accomplishments have been acknowledged with the attribution of the Nobel Prize in Physiology or Medicine in 2002. Because the worm contains less than 1000 cells (959 cells in adult hermaphrodites) and cellular pathways are conserved, C. elegans rapidly became a model of choice to study how cells into the animal are regulated precisely in time and space to produce a fertile adult. Indeed, C. elegans has allowed the discovery and increased our comprehension of many important cellular pathways required in embryogenesis and during the animal development. Among them, the recent discovery of the microRNAs has completely changed our vision of how gene expression is controlled.
New pathways regulating cell differentiation: the microRNAs
In 1993, a new function has been associated to RNA molecules with the discovery of lin-4, a small 22 nucleotides RNA implicated in gene regulation. Conducting a genetic screen to find essential components of the larvae development in C. elegans, Victor Ambros and Gary Ruvkun groups found a lesion in one of their mutant in a gene called lin-4 (abnormal cell LINeage), which did not encode any protein but was essential for the developmental timing of the worm (Lee et al., 1993; Wightman et al., 1993) . This tiny RNA, called micro-RNA, inhibits protein accumulation through a nonperfect RNA-RNA interaction with a complementary sequence found in the non-coding region of a specific messenger RNA. This discovery was intriguing because eucaryotic gene regulation was known to be carried out by proteins and not by RNA molecules. Seven years later, another example emerged with the discovery of let-7 (LEThal), an additional gene implicated in C. elegans development . The report of a second example along with the observation that the let-7 microRNA and its target, lin-41, were phylogenically conserved provoked a hunt for the identification of microRNAs in other animal species. These discoveries led to the creation of a new and fertile field of research in biology: the gene regulation by small non-coding RNAs.
So far, studies performed with C. elegans indicate that microRNAs are playing an important role in cellular development. Animals carrying mutations in either lin-4 or let-7 microRNAs displayed abnormal body cuticules (Lee et al., 1993; Reinhart et al., 2000) . Other studies have shown that microRNAs are important in insuring asymmetrical expression of a taste receptor in a pair of sensory neurons in C. elegans (Johnston and Hobert, 2003; Chang et al., 2004; Johnston et al., 2005) . Furthermore, alteration of specific microRNAs leads to major defects such as improper cell proliferation and tissues differentiation important for the animal development (Abbott et al., 2005; Li et al., 2005) . Thus, these studies indicate that altering microRNA functions leads to inappropriate cell proliferation and differentiation, a hallmark of cancer.
The development of the vulva is guided by the Ras and the Notch pathways
Studying the vulva development in C. elegans contributes to understand biological events important for development of all animals (reviewed by Sternberg, 2005) . Genetic screens performed with C. elegans have contributed to our understanding of how the Notch and the Ras pathways tightly control cell proliferation and cell differentiation implicated in vulva formation ( Figure 1a ; for further details see review by Sundaram, 2005) . During the post-embryonic development of the nematode, the vulva is formed from six precursor cells (called vulva precursor cells (VPCs)) able to adopt three different fates (Figure 1a) . The gonadal anchor cell expresses epidermal growth factor (EGF)/abnormal cell LINeage (LIN)-3, which stimulates the EGF receptor (EGFR)/LET-23, the starting point of the Ras/LET-60 activation in the VPC P6.p. This activation of the Ras pathway promotes the first (11) fate and initiates the second (21) fate to the neighbouring cells, P5.p and P7.p, by the interaction of the Notch/LIN-12 receptor with its ligand Delta/Serrate/Lag-2 (DSL)/LAG-2 (Lin-12 And Glp-1 phenotype) expressed by P6.p. Therefore, every single VPC is under control of different intra-and extracellular signals that initiate their differentiation. The crosstalk between the Ras and the Notch pathway within P5.p, P6.p and P7.p VPCs allows an extremely precise differentiation.
The Ras signaling pathway is the most important pathway controlling cell proliferation in mammals. Mutations in this gene produce an uncontrolled proliferation of cells leading to malignant transformation. The Ras gene is frequently mutated in many tumours (reviewed by Malumbres and Barbacid, 2003) . In C. elegans, components of the Ras signaling pathway are highly conserved and also act as a molecular switch that determine cell fate. As observed in mammals, mutations affecting either the Ras or the Notch pathway in C. elegans cause a serious defect in cellular proliferation and differentiation. Mutant strains carrying defect in genes involved in these pathways lead to an absence of vulva or a multiple vulva phenotypes (Figure 1b ).
Because the nematode C. elegans displays many features that are ideal for model systems (the development of every cell is known with great detail; it has a rapid lifespan; this is a powerful genetic model and; it is extremely simple to work with in a lab environment), its has rapidly been considered as a great animal system to increase our understanding of carcinogenesis. Many proto-oncogenes and tumour suppressors such as Bcl-2 and Retinoblastoma are extensively studied in C. elegans (reviewed by Poulin et al., 2004) and the worm has a clear potential to be used for the high-throughput screening of anticancer drugs (Hartwell et al., 1997; Schumacher and Gartner, 2006) .
Recently, two studies from Greenwald's group and Slack and collaborators have shown that microRNAs can also act as tumour suppressors by controlling the Notch and the Ras pathways in the vulva development. The Vav oncogene orthologue, VAV-1, is regulated by miR-61
The importance of the Notch signaling pathway in C. elegans is clearly illustrated in worm strains carrying gain-of-function alleles. Animals with mutations in the Notch/lin-12 have multiple vulva instead of one (Sternberg and Horvitz, 1989) . That phenotype is caused by a defect in cellular differentiation; all VPCs adopt the second fate. In their quest to understand how Notch/ lin-12 specified the cellular second fate during the vulval development, Yoo and Greenwald (2005) discovered an important role for the microRNA miR-61. They first observed that altering alg-1 gene function (an essential gene for the microRNA pathway (Grishok et al., 2001) ) in animal leads to the expression of a third fate marker into P5.p and P7.p. This observation indicates that a microRNA may be implicated in this cellular differentiation pathway. Thus, using bioinformatics approach and fluorescence localization, Yoo and Greenwald (2005) demonstrated that the transcriptional switch in P5.p and P7.p mediated by the Ras/let-60 pathway in P6.p, induces the specific expression of miR-61 in these VPCs. The ectopic expression of the microRNA in P6.p cell induces the second cellular fate instead of the first fate. These experiments demonstrate that miR-61 is crucial for the developmental control of the vulva in C. elegans, by either activating or abrogating a signalization pathway. They discovered that the miR-61 target is the vav-1 gene, the orthologue of the proto-oncogene Vav in vertebrates. Their data showed that the regulation of VAV-1 expression by the miR-61 microRNA keeps Notch/LIN-12 active and, thus insure that the differentiation to the second cellular fate occurs in P5.p and P7.p. The pro-oncogene Vav gene family includes vav 1,2,3 (review in Bustelo, 2001 ). In vertebrates, Vav1 is playing a role in many signalization pathways including the NF-kB and MAP-kinase pathways. Vav is implicated in the development and in the function of B and T lymphocytes (Tarakhovsky et al., 1995) and immortalized neuroblastoma cell lines have ectopic expression of VAV proto-oncogene (Hornstein et al., 2003) . Furthermore, this gene was recently found to be involved in a large number of pancreatic tumours (Denicola and Tuveson, 2005) . Despite the fact that Yoo and Greenwald have not observed any link between Vav and microRNA in mammalian cells, their data obtained using C. elegans as a model system suggest that microRNAs controls cellular development by regulating oncogene expression.
The Ras protein is regulated by the let-7 microRNA family
Previous studies have shown that the let-7 microRNA negatively controls at least two targets genes, lin-41 and hunchback-like gene hbl-1 (Abrahante et al., 2003; Lin et al., 2003) . Genetics approaches in C. elegans have shown that the loss-of-function of let-7 microRNA is partially suppressed by lin-41 and hbl-1 mutations Abrahante et al., 2003; Lin et al., 2003) . The partial suppression indicates that other let-7 targets exist and their identification will help to uncover functions of this microRNA. To achieve this task, Frank Slack's group undertook a computational screen Johnson et al., 2005) . Among the genes in which let-7 complementary sites can be found at their 3 0 untranslated region (3 0 UTR), they noticed the let-60 gene, the orthologue of the oncogene Ras . As observed with lin-41 and hbl-1, the lossof-function of Ras/let-60 gene partially suppress let-7 mutant phenotype indicating the genetic interaction between these two genes. In addition, when a reporter gene fused to the Ras/let-60 3 0 UTR is expressed in the same tissue of the let-7 microRNA, they observed an important reduction in the expression of the reporter when the animal reach L4 stage, the stage in which let-7 is expressed . Thus, their data strongly suggest that Ras/LET-60 is downregulated by let-7 microRNA or by the members of its family (i.e. highly conserved sequences between members; Lau et al., 2001; Ambros et al., 2003; Grad et al., 2003; Lim et al., 2003) .
As described previously, Ras/let-60 is playing an important role in vulval development. Among the let-7 genes family, Slack and co-workers showed that the closest homologue of let-7, the miR-84 microRNA, is strongly expressed in the anchor cells and the P5.p and P7.p cells and barely expressed in the P6.p cell; an expression pattern that can favour interaction with Ras/LET-60 (highly expressed in P6.p). Furthermore, overexpression of miR-84 induces abnormal development of the vulva. As that Ras/ LET-60 signalling pathway is active in the P6.p cell and miR-84 express in all VPCs with the exception of P6.p, they wanted to examine if this microRNA could negatively regulates Ras/let-60 expression in cells that do not undergo the first vulval fate. Mutations causing gain-of-function of Ras/let-60 lead to the expression of Ras gene into all VPCs, the first fate is adopted by non-P6.p cells and thus, the animal shows multiple vulva (Figure 1b ; Beitel et al., 1990) . When they overexpressed miR-84, it suppresses partially the multiple vulva phenotype observed when Ras/LET-60 is overexpressed. Moreover, by using reporter gene containing the Ras/ let-60 3 0 UTR region expressed into the VPC cells, they showed that this region was sufficient to attenuate the reporter expression into the P5.p and P7.p cells. Thus, their data clearly demonstrated members of the let-7 microRNA family regulate Ras/let-60 gene expression through the 3 0 UTR region. The interesting data observed in C. elegans by Slack and co-workers took a greater significance when they looked for the existence of a similar mechanism of regulation of Ras genes in human cells. They found the all three human Ras genes, H-Ras, K-Ras and N-Ras, have complementary sites for let-7 and miR-84 human homologues in their 3 0 UTRs. As previously observed in C. elegans, they showed that the microRNAs act as tumour suppressors in C. elegans G Jannot and MJ Simard level expression of a reporter gene carrying these 3 0 UTRs is downregulated by let-7. In addition, when they exogenously provided let-7 microRNA in a cell line that do not express it or when they blocked the let-7 function with a sequence-specific inhibitor (Hutva´gner et al., 2004; Meister et al., 2004) , they noticed that the level of endogenous Ras protein is significantly reduced or enhanced, respectively. Based on the data obtained, Slack and co-workers decided to look for a potential correlation between the expression of let-7 and Ras proteins in cancer tissues. When they first monitored the level of let-7 in tissues samples from different patients using microarrays analysis, they noticed that tissues from patients with lung cancer have a lower expression of let-7. Interestingly, they monitored a significant increase of the level of Ras proteins in tissues with low let-7 expression. Their data showed that the expression of the let-7 microRNA inversely correlates with the expression of Ras genes in lung cancer. Interestingly, others have reported that the overexpression of let-7 inhibited growth of a lung cancer cell line in vitro (Takamizawa et al., 2004) . These observations strongly suggest the role of the let-7 microRNA family as a tumour suppressor in animals.
MicroRNAs key players in tumorigenesis: a lesson from worms
These two studies clearly illustrate the importance of the microRNAs to insure the correct role of the Notch and the Ras pathways in the cell proliferation and differentiation implicated in the vulval development in C. elegans. As the misregulation of either Notch or Ras level are frequent in human cancers (reviewed by Malumbres and Barbacid, 2003; Radtke and Raj, 2003) , data from Greenwald and Slack groups allow to suggest that microRNAs might be directly associated with tumorigenesis implicating the Notch and the Ras pathway. Thus, these observations, and particularly Slack and co-workers paper, implicate microRNAs as tumour suppressors (Figure 2a) . A search for microRNAs binding sites in the worm genome indicates that these small RNAs may regulate expression of many oncogenes as well as tumour suppressors (Table 1) . Therefore, in addition to their tumour suppressors activities, the microRNAs could also potentially act as oncogenes and increase tumour formation and proliferation. We can envision that a specific microRNA that regulates tumour suppressor, can lead to tumour formation if the microRNA is overexpressed (Figure 2b ). The great potential of C. elegans as animal model will surely help to better understand microRNAs functions in this regard.
Once again, the tiny crawling creature called C. elegans had brought important insights in animal biology and in our comprehension of cancer. Undoubtedly, we can expect many major contributions from the studies undertaken with the nematode in the near future that will bring us closer to tackle this serious disease. In C. elegans, miR-84 restrains Ras gene orthologue, let-60 expression. A significant diminution of miR-84 expression increases the level of LET-60 protein and, thus leads to multiple vulva phenotype (extra vulva are in purple). In humans, let-7 microRNA participates to maintain the appropriate cellular Ras protein level. If the microRNA expression is abolished, the amount of the Ras protein will be increase and thus tumours will be generated. (b) Potential role of microRNA as oncogene. The overexpression of microRNA that controls a tumour suppressor expression could lead to tumour formation. 
